[Federal Register Volume 70, Number 213 (Friday, November 4, 2005)]
[Notices]
[Pages 67180-67181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-21989]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel, Clinical Trials of 
Silymarin for Liver Diseases.
    Date: December 1, 2005.
    Time: 8 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 
20852.

[[Page 67181]]

    Contact Person: Martina Schmidt, PhD, Scientific Review 
Administrator, Office of Scientific Review, Nat'l Center for 
Complementary and Alt Medicine, 6707 Democracy Blvd., Suite 401, 
Bethesda, MD 20892. 301-594-3456. [email protected].

    Dated: October 28, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-21989 Filed 11-3-05; 8:45am]
BILLING CODE 4140-01-M